Literature DB >> 812098

Primary structure of a deleted human lambda type immunoglobulin light chain containing carbohydrate: protein Sm lambda.

F A Garver, L Chang, J Mendicino, T Isobe, E F Osserman.   

Abstract

An internal molecular deletion occurring in a human lambda type immunoglobulin light (L)-chain (Sm lambda) has been defined by sequence analysis. The Sm protein was isolated from the urine of a patient with a plasma cell dyscrasia involving the synthesis of an IgG molecule with both deleted gamma and lambda subunits. The Sm lambda polypeptide chain has an approximate molecular weight of 15,000 and contains 135 amino-acid residues. The constant (C) region is fully intact, comprising 105 residues, whereas the variable region (V) has only 30 residues. The V-region segment represents residues 1 through 30 of normal lambda chains and possesses considerable homology (87%) to lambda chains of subgroup II. Since lambdaII proteins normally contain 216 amino-acid residues, the defect represents an intramolecular deletion of 81 residues, which is entirely confined to the carboxyterminal three-quarters segment of the V-region, with a resumption of normal synthesis at a glutaminyl residue at position 110, the initiation point of the C-region. Carbohydrate is attached to an Asx residue at position 25, in the first hypervariable region, associated with the sequence triplet Asx-Ser-Ser, which is postulated to be a common recognition site for glycosylation of immunoglobulins. The carbohydrate moiety is a complex oligosaccharide with a branched chain structure containing sialic acid, fucose, mannose, N-acetylglucosamine, and galactose. These structural studies and other findings suggest that restricted areas in the DNA of immunoglobulin genes, such as the hinge regions of heavy (H) and light (L) chains and the hypervariable regions, are particularly susceptible to breakage and reunion. We postulate that the genetic defect of protein Sm could have originated from a somatic mutational event in the plasmacyte precursor during or after the integration of the V and C genes. These studies provide additional support for the hypothesis and two distinct structural genes encode a single immunoglobulin polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 812098      PMCID: PMC388762          DOI: 10.1073/pnas.72.11.4559

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Protein Hal: partial deletion of a " " immunoglobulin gene(s) and apparent reinitiation at an internal AUG codon.

Authors:  B Frangione; L Lee; E Haber; K J Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

2.  The molecular basis of antibody formation: a paradox.

Authors:  W J Dreyer; J C Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

3.  Two types of lambda polypeptide chains in human immunoglobulins based on an amino acid substitution at position 190.

Authors:  E Appella; D Ein
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

4.  The N- and c-terminal amino acid sequences of the heavy chain from a pathological human immunoglobulin IgG.

Authors:  E M Press; P J Piggot; R R Porter
Journal:  Biochem J       Date:  1966-05       Impact factor: 3.857

5.  Detection in normal plasma of immunoglobulin resembling the protein of gamma-chain disease.

Authors:  C W Lam; G T Stevenson
Journal:  Nature       Date:  1973-12-14       Impact factor: 49.962

6.  [Genetic polymorphism in the constant part of human immunoglobin lambda type L-chains. II].

Authors:  M Hess; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-05

Review 7.  Somatic translocation of antibody genes.

Authors:  J A Gally; G M Edelman
Journal:  Nature       Date:  1970-07-25       Impact factor: 49.962

8.  [The complete amino acid sequence of Bence Jones protein New (lambda-type). Subgroups in the variable part of immunoglobulin L-chains of the lambda-type].

Authors:  B Langer; M Steinmetz-Kayne; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-07

9.  Partial deletion in the heavy chain disease protein ZUC.

Authors:  B Frangione; C Milstein
Journal:  Nature       Date:  1969-11-08       Impact factor: 49.962

10.  Molecular defect in a gamma-2 heavy chain.

Authors:  S M Cooper; E C Franklin; B Frangione
Journal:  Science       Date:  1972-04-14       Impact factor: 47.728

View more
  7 in total

1.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

2.  The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.

Authors:  T Tveteraas; K Sletten; P Westermark
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

Review 3.  Genetic determination of antibody specificity. Gene translocation and fusion, the molecular basis for the differentiation of the antibody-producing cell.

Authors:  N Hilschmann; H U Barnikol; H Kratzin; P Altevogt; M Engelhard; S Barnikol-Watanabe
Journal:  Naturwissenschaften       Date:  1978-12

4.  The effect of paraprotein on platelet aggregation.

Authors:  Irena Djunic; Ivo Elezovic; Vesna Ilic; Nadezda Milosevic-Jovcic; Jelena Bila; Nada Suvajdzic-Vukovic; Darko Antic; Ana Vidovic; Dragica Tomin
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

5.  Human heavy chain disease protein WIS: implications for the organization of immunoglobulin genes.

Authors:  E C Franklin; F Prelli; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Human immunoglobulin C lambda 6 gene encodes the Kern+Oz-lambda chain and C lambda 4 and C lambda 5 are pseudogenes.

Authors:  P Dariavach; G Lefranc; M P Lefranc
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 7.  Correlation of glycosylation forms with position in amino acid sequence.

Authors:  L Pollack; P H Atkinson
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.